DaVita(NYSE) DVA

DaVita Inc. helps people with kidneys that do not work. It provides dialysis to clean blood when kidneys fail. These services meet an essential need for many patients.

Caring for Kidneys Every Day

• U.S. Dialysis: Outpatient centers and home treatments for kidney failure; generated $5.954 billion for the six months ended June 30, 2026.
• Ancillary Services: Lab work, international clinics, and specialty care management; generated $1.054 billion for the six months ended June 30, 2026.
• Integrated Kidney Care: Coordination of health services for chronic kidney disease; manages over 64,000 patients in risk-based plans.
• International Operations: Dialysis centers located in 14 countries outside the United States; operated 595 centers as of June 30, 2026.

Expanding Care and New Methods

• Added 13 international centers through acquisitions during the six months ended June 30, 2026.
• Began rolling out expanded hemodialysis, which is a therapy that clears more toxins from the blood.
• Purchased a noncontrolling interest in Elara Caring on July 20, 2026.
• Increased integrated care enrollment to approximately 70,600 total patients by mid-2026.

Large Scale and Specialized Labs

DaVita operates 2,671 dialysis centers across the United States to provide life-sustaining medical treatments. The company manages specialized laboratories that perform vital tests to monitor the health of patients with kidney disease.

Key Numbers from Recent Reports

• Total consolidated revenues were $3.554 billion in the second quarter of 2026, up 4.0% from the first quarter.
• Free cash flow was $396 million for the six months ended June 30, 2026, compared to $112 million in 2025.
• U.S. dialysis revenue per treatment rose 3.6% for the six-month period ended June 30, 2026.
• Operating income reached $579 million in the second quarter of 2026.
• The company repurchased 5.2 million shares of common stock during the first half of 2026.

A Global Leader in Kidney Care

DaVita has transformed from a U.S. clinic operator into a global healthcare company specializing in kidney care. Its focus on integrated care and international expansion supports its role as a major provider of chronic disease management.